Nucleic acid binding, small nuclear ribonucleo
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0032991 | protein-containing complex | 1 | 11 |
GO:1990904 | ribonucleoprotein complex | 2 | 11 |
GO:0005634 | nucleus | 5 | 1 |
GO:0005681 | spliceosomal complex | 3 | 1 |
GO:0005682 | U5 snRNP | 5 | 1 |
GO:0005684 | U2-type spliceosomal complex | 4 | 1 |
GO:0005685 | U1 snRNP | 5 | 1 |
GO:0005686 | U2 snRNP | 5 | 1 |
GO:0005687 | U4 snRNP | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0030532 | small nuclear ribonucleoprotein complex | 3 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0046540 | U4/U6 x U5 tri-snRNP complex | 6 | 1 |
GO:0071004 | U2-type prespliceosome | 5 | 1 |
GO:0071010 | prespliceosome | 4 | 1 |
GO:0071013 | catalytic step 2 spliceosome | 3 | 1 |
GO:0097525 | spliceosomal snRNP complex | 4 | 1 |
GO:0097526 | spliceosomal tri-snRNP complex | 5 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0120114 | Sm-like protein family complex | 2 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
Related structures:
AlphaFold database: A0A3Q8IEE4
Term | Name | Level | Count |
---|---|---|---|
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 1 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 1 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006397 | mRNA processing | 7 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0008380 | RNA splicing | 7 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 106 | 108 | PF00675 | 0.728 |
CLV_PCSK_KEX2_1 | 106 | 108 | PF00082 | 0.656 |
CLV_PCSK_KEX2_1 | 60 | 62 | PF00082 | 0.419 |
CLV_PCSK_PC1ET2_1 | 106 | 108 | PF00082 | 0.656 |
CLV_PCSK_PC1ET2_1 | 60 | 62 | PF00082 | 0.419 |
CLV_PCSK_SKI1_1 | 22 | 26 | PF00082 | 0.344 |
CLV_PCSK_SKI1_1 | 98 | 102 | PF00082 | 0.747 |
DOC_CYCLIN_RxL_1 | 22 | 32 | PF00134 | 0.574 |
DOC_MAPK_gen_1 | 60 | 68 | PF00069 | 0.576 |
DOC_MAPK_HePTP_8 | 66 | 78 | PF00069 | 0.558 |
DOC_MAPK_MEF2A_6 | 60 | 67 | PF00069 | 0.581 |
DOC_MAPK_MEF2A_6 | 69 | 78 | PF00069 | 0.528 |
DOC_MAPK_NFAT4_5 | 60 | 68 | PF00069 | 0.624 |
DOC_PP1_RVXF_1 | 25 | 32 | PF00149 | 0.574 |
DOC_WW_Pin1_4 | 55 | 60 | PF00397 | 0.512 |
LIG_Clathr_ClatBox_1 | 28 | 32 | PF01394 | 0.596 |
LIG_FHA_1 | 23 | 29 | PF00498 | 0.570 |
LIG_SH2_CRK | 4 | 8 | PF00017 | 0.588 |
LIG_SH2_STAT5 | 4 | 7 | PF00017 | 0.563 |
LIG_SUMO_SIM_anti_2 | 75 | 80 | PF11976 | 0.692 |
LIG_SUMO_SIM_par_1 | 71 | 77 | PF11976 | 0.550 |
LIG_TRAF2_1 | 42 | 45 | PF00917 | 0.624 |
LIG_UBA3_1 | 6 | 12 | PF00899 | 0.582 |
MOD_CDC14_SPxK_1 | 58 | 61 | PF00782 | 0.536 |
MOD_CDK_SPK_2 | 55 | 60 | PF00069 | 0.578 |
MOD_CDK_SPxK_1 | 55 | 61 | PF00069 | 0.536 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.700 |
MOD_GlcNHglycan | 98 | 101 | PF01048 | 0.541 |
MOD_GSK3_1 | 96 | 103 | PF00069 | 0.787 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.551 |
MOD_Plk_4 | 74 | 80 | PF00069 | 0.565 |
MOD_ProDKin_1 | 55 | 61 | PF00069 | 0.512 |
TRG_ENDOCYTIC_2 | 4 | 7 | PF00928 | 0.593 |
TRG_ER_diLys_1 | 106 | 111 | PF00400 | 0.728 |
TRG_NLS_MonoCore_2 | 105 | 110 | PF00514 | 0.794 |
TRG_NLS_MonoExtN_4 | 106 | 111 | PF00514 | 0.721 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5Y3 | Leptomonas seymouri | 80% | 100% |
A0A0S4J6U1 | Bodo saltans | 49% | 100% |
A0A1X0NSU4 | Trypanosomatidae | 59% | 100% |
A0A3R7MNH5 | Trypanosoma rangeli | 58% | 97% |
A4HFX2 | Leishmania braziliensis | 91% | 100% |
A4I304 | Leishmania infantum | 100% | 100% |
C9ZJF6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
E9ADH7 | Leishmania major | 97% | 100% |
E9AZA1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
P91918 | Caenorhabditis elegans | 43% | 69% |
Q10163 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 44% | 76% |
Q9D2U5 | Mus musculus | 38% | 89% |